Redmile Biopharma Investments Iii, L.p. - Net Worth and Insider Trading
Redmile Biopharma Investments Iii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Redmile Biopharma Investments Iii, L.p. owns 2 companies in total, including Entrada Therapeutics Inc (TRDA) , and Invivyd Inc (IVVD) .
Insider Ownership Summary of Redmile Biopharma Investments Iii, L.p.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TRDA | Entrada Therapeutics Inc | 2021-10-28 | 10 percent owner |
| IVVD | Invivyd Inc | 2021-08-05 | 10 percent owner |
Redmile Biopharma Investments Iii, L.p. Trading Performance
Redmile Biopharma Investments Iii, L.p. Ownership Network
Ownership Network List of Redmile Biopharma Investments Iii, L.p.
Ownership Network Relation of Redmile Biopharma Investments Iii, L.p.
Redmile Biopharma Investments Iii, L.p. Owned Company Details
What does Entrada Therapeutics Inc do?
Who are the key executives at Entrada Therapeutics Inc?
Redmile Biopharma Investments Iii, L.p. is the 10 percent owner of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Financial Officer Kory James Wentworth , 10 percent owner Mpm Bioventures 2018, L.p. , and 10 percent owner Mpm Bioventures 2014, L.p. .
Entrada Therapeutics Inc (TRDA) Insider Trades Summary
Over the past 18 months, Redmile Biopharma Investments Iii, L.p. made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 62,279 shares made by Natarajan Sethuraman , a net sale of 37,960 shares made by Kory James Wentworth , and a net purchase of 45,368 shares made by Peter S Kim .
In summary, during the past 3 months, insiders sold 1,784 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 1,784 shares. During the past 18 months, 230,656 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 185,288 shares.
Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entrada Therapeutics Inc Insider Transactions
Redmile Biopharma Investments Iii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Redmile Biopharma Investments Iii, L.p.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Redmile Biopharma Investments Iii, L.p.'s mailing address is: San Francisco Ca 94129.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
